BCA
AGN

Berman Capital Advisors’s Allergan plc AGN Stock Holding History

Berman Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-491
Closed -$86K – 1939
2020
Q1 		$86K Buy
491
+171
+53% +$32.2K 0.03% 220
2019
Q4 		$60K Buy
320
+18
+6% +$3.25K 0.02% 293
2019
Q3 		$50K Buy
302
+55
+22% +$8.96K 0.02% 301
2019
Q2 		$41K Buy
247
+9
+4% +$1.25K 0.01% 344
2019
Q1 		$34K Buy
238
+78
+49% +$11.3K 0.01% 347
2018
Q4 		$20K Buy
+160
New +$26.2K 0.01% 389

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Berman Capital Advisors's AGN Position: Q2 2020 in Review

Berman Capital Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 491 shares — an estimated $86K sold.

Berman Capital Advisors first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $86K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Berman Capital Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Berman Capital Advisors sold 491 Allergan plc shares in Q2 2020, an estimated $86K.
  • Berman Capital Advisors first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Berman Capital Advisors's Allergan plc position peaked at $86K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Berman Capital Advisors's 13F filing for Q2 2020, filed 6 Aug 2020.